Simcere Pharmaceutical Group (HKG:2096) posted an attributable net profit of 828.7 million yuan in the first half, up 37.9% from 601.1 million yuan a year ago.
Earnings per share came in at 0.32 yuan, up from 0.25 yuan a year earlier, according to a Friday filing with the Hong Kong Stock bourse.
Total revenue in the six months ended June 30 increased to 4.58 billion yuan from 3.59 billion yuan.
The company did not declare an interim dividend.